BioCentury | Jan 3, 2020
Emerging Company Profile

Click: personalized digital therapeutics for cognitive, neurobehavioral disorders

Click is developing a pipeline of personalized prescription digital therapeutics that could be used alone or in combination with traditional therapeutics to treat cognitive and neurobehavioral disorders. Launched in 2012, Click Therapeutics Inc. markets a...
BC Extra | Dec 12, 2019
Clinical News

PureTech’s Akili reports positive data for depression video game

In a busy week for PureTech affiliates, Akili reported data for its video game-based digital therapeutic to help treat cognitive impairments associated with depression. PureTech Health plc (LSE:PRTC) founded Akili Interactive Labs Inc., which raised...
Items per page:
1 - 2 of 2